FDA Approves Historic Roflumilast Foam 0.3% For Seborrheic Dermatitis

Press/Media

Period	1 Dec 2023

Media coverage

Title FDA Approves Historic Roflumilast Foam 0.3% For Seborrheic Dermatitis
Media name/outlet Dermatology Times
Country/Territory United States
Date 1/12/23
Persons Peter Lio

Title	FDA Approves Historic Roflumilast Foam 0.3% For Seborrheic Dermatitis
Media name/outlet	Dermatology Times
Country/Territory	United States
Date	1/12/23
Persons	Peter Lio